A Phase I, Open-label, Fixed Sequence Crossover Study to Investigate the Effect of Coadministration of Sotorasib on the Pharmacokinetics of Rosuvastatin, a Breast Cancer Resistance Protein Substrate, in Healthy Subjects
Latest Information Update: 16 Aug 2023
At a glance
- Drugs Rosuvastatin (Primary) ; Sotorasib (Primary)
- Indications Brain metastases; Colorectal cancer; Non-small cell lung cancer; Pancreatic cancer; Solid tumours
- Focus Pharmacokinetics
- Sponsors Amgen
- 24 Mar 2023 Results assessing effect of coadministration of sotorasib on the pharmacokinetics of rosuvastatin, in healthy subjects, presented at the 124th Annual Meeting of the American Society for Clinical Pharmacology and Therapeutics.
- 15 Oct 2021 Status changed from active, no longer recruiting to completed.
- 05 Oct 2021 Status changed from recruiting to active, no longer recruiting.